{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T12:55:16Z","timestamp":1782219316855,"version":"3.54.5"},"reference-count":115,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12180-4","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T12:34:27Z","timestamp":1782218067000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Immune-smart nanocarriers for nucleic acid oncology: engineering biomaterials for safe, precise, and durable responses"],"prefix":"10.1007","volume":"53","author":[{"given":"Kanaka Durga Devi","family":"Nelluri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SK. Abdul","family":"Rahaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Padamata Sai","family":"Rohith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavana","family":"Alaparthi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minakshi","family":"Kommoju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nalam Vineela","family":"Nirmala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaik","family":"Befathima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3738-4381","authenticated-orcid":false,"given":"Shriyansh","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajad","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh","family":"Sahu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,23]]},"reference":[{"key":"12180_CR1","doi-asserted-by":"publisher","unstructured":"Kulkarni JA, Witzigmann D, Thomson SB, Chen S, Leavitt BR, Cullis PR et al (2021) The current landscape of nucleic acid therapeutics. Nature Nanotechnology [Internet]. ;16(6):630\u201343. Available from: https:\/\/doi.org\/10.1038\/s41565-021-00898-0","DOI":"10.1038\/s41565-021-00898-0"},{"key":"12180_CR2","doi-asserted-by":"publisher","unstructured":"Setten RL, Rossi JJ, Han SP (2019) The current state and future directions of RNAi-based therapeutics. Nature Reviews Drug Discovery [Internet]. 18(6):421\u201346. Available from: https:\/\/doi.org\/10.1038\/s41573-019-0017-4","DOI":"10.1038\/s41573-019-0017-4"},{"key":"12180_CR3","doi-asserted-by":"publisher","unstructured":"Sahin U, T\u00fcreci \u00d6 (2018) Personalized vaccines for cancer immunotherapy. Science [Internet]. 359(6382):1355\u201360. Available from: https:\/\/doi.org\/10.1126\/science.aar7112","DOI":"10.1126\/science.aar7112"},{"key":"12180_CR4","doi-asserted-by":"publisher","unstructured":"Riley RS, June CH, Langer R, Mitchell MJ (2019) Delivery technologies for cancer immunotherapy. Nature Reviews Drug Discovery [Internet]. 18(3):175\u201396. Available from: https:\/\/doi.org\/10.1038\/s41573-018-0006-z","DOI":"10.1038\/s41573-018-0006-z"},{"key":"12180_CR5","doi-asserted-by":"publisher","unstructured":"Whitehead KA, Langer R, Anderson DG (2009) Knocking down barriers: advances in siRNA delivery. Nature Reviews Drug Discovery [Internet]. 8(2):129\u201338. Available from: https:\/\/doi.org\/10.1038\/nrd2742","DOI":"10.1038\/nrd2742"},{"key":"12180_CR6","doi-asserted-by":"publisher","unstructured":"Shi J, Kantoff PW, Wooster R, Farokhzad OC (2016) Cancer nanomedicine: progress, challenges and opportunities. Nature Reviews Cancer [Internet]. 17(1):20\u201337. Available from: https:\/\/doi.org\/10.1038\/nrc.2016.108","DOI":"10.1038\/nrc.2016.108"},{"key":"12180_CR7","doi-asserted-by":"publisher","unstructured":"Mura S, Nicolas J, Couvreur P (2013) Stimuli-responsive nanocarriers for drug delivery, Nature Materials, vol. 12, no. 11, pp. 991\u20131003, Oct. https:\/\/doi.org\/10.1038\/nmat3776","DOI":"10.1038\/nmat3776"},{"key":"12180_CR8","doi-asserted-by":"publisher","unstructured":"Hou X, Zaks T, Langer R, Dong Y (2021) Lipid nanoparticles for mRNA delivery. Nature Reviews Materials [Internet]. 6(12):1078\u201394. Available from: https:\/\/doi.org\/10.1038\/s41578-021-00358-0","DOI":"10.1038\/s41578-021-00358-0"},{"key":"12180_CR9","doi-asserted-by":"publisher","unstructured":"Zhang Y, Chan HF, Leong KW (2012) Advanced materials and processing for drug delivery: The past and the future. Advanced Drug Delivery Reviews [Internet]. 65(1):104\u201320. Available from: https:\/\/doi.org\/10.1016\/j.addr.2012.10.003","DOI":"10.1016\/j.addr.2012.10.003"},{"key":"12180_CR10","doi-asserted-by":"publisher","unstructured":"Moghimi SM, Hunter AC, Andresen TL (2011) Factors controlling nanoparticle pharmacokinetics: An integrated analysis and perspective. the annual review of pharmacology and toxicology [Internet]. 52(1):481\u2013503. Available from: https:\/\/doi.org\/10.1146\/annurev-pharmtox-010611-134623","DOI":"10.1146\/annurev-pharmtox-010611-134623"},{"key":"12180_CR11","doi-asserted-by":"publisher","unstructured":"Fadeel B, Farcal L, Hardy B, V\u00e1zquez-Campos S, Hristozov D, Marcomini A et al (2018) Advanced tools for the safety assessment of nanomaterials. Nature Nanotechnology [Internet]. 13(7):537\u201343. Available from: https:\/\/doi.org\/10.1038\/s41565-018-0185-0","DOI":"10.1038\/s41565-018-0185-0"},{"key":"12180_CR12","doi-asserted-by":"publisher","unstructured":"Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R (2020) Engineering precision nanoparticles for drug delivery. Nature Reviews Drug Discovery [Internet]. 20(2):101\u201324. Available from: https:\/\/doi.org\/10.1038\/s41573-020-0090-8","DOI":"10.1038\/s41573-020-0090-8"},{"key":"12180_CR13","doi-asserted-by":"publisher","unstructured":"Prazeres PHDM, Ferreira H, Costa PAC, Da Silva W, Alves MT, Padilla M et al (2023) Delivery of plasmid DNA by ionizable lipid nanoparticles to induce CAR expression in T cells. International Journal of Nanomedicine [Internet]. Volume 18:5891\u2013904. Available from: https:\/\/doi.org\/10.2147\/ijn.s424723","DOI":"10.2147\/ijn.s424723"},{"key":"12180_CR14","doi-asserted-by":"publisher","unstructured":"Goldberg MS (2019) Improving cancer immunotherapy through nanotechnology. Nature Reviews Cancer [Internet]. 19(10):587\u2013602. Available from: https:\/\/doi.org\/10.1038\/s41568-019-0186-9","DOI":"10.1038\/s41568-019-0186-9"},{"key":"12180_CR15","doi-asserted-by":"publisher","unstructured":"Irvine DJ, Dane EL (2020) Enhancing cancer immunotherapy with nanomedicine. Nature Reviews Immunology [Internet]. 20(5):321\u201334. Available from: https:\/\/doi.org\/10.1038\/s41577-019-0269-6","DOI":"10.1038\/s41577-019-0269-6"},{"key":"12180_CR16","doi-asserted-by":"publisher","unstructured":"Mohtar N, Parumasivam T, Gazzali AM, Tan CS, Tan ML, Othman R et al (2021) Advanced Nanoparticle-Based drug delivery systems and their cellular evaluation for Non-Small Cell Lung Cancer treatment. Cancers [Internet]. 13(14):3539. Available from: https:\/\/doi.org\/10.3390\/cancers13143539","DOI":"10.3390\/cancers13143539"},{"key":"12180_CR17","doi-asserted-by":"publisher","unstructured":"Kawamoto Y, Wu Y, Takahashi Y, Takakura Y (2023) Development of nucleic acid medicines based on chemical technology. Advanced Drug Delivery Reviews [Internet]. 199:114872. Available from: https:\/\/doi.org\/10.1016\/j.addr.2023.114872","DOI":"10.1016\/j.addr.2023.114872"},{"key":"12180_CR18","doi-asserted-by":"publisher","unstructured":"Chen Q, Sun L, Chen ZJ (2016) Regulation and function of the cGAS\u2013STING pathway of cytosolic DNA sensing. Nature Immunology [Internet]. 17(10):1142\u20139. Available from: https:\/\/doi.org\/10.1038\/ni.3558","DOI":"10.1038\/ni.3558"},{"key":"12180_CR19","doi-asserted-by":"publisher","unstructured":"De Weerd NA, Nguyen T (2012) The interferons and their receptors\u2014distribution and regulation. Immunology and Cell Biology [Internet]. 90(5):483\u201391. Available from: https:\/\/doi.org\/10.1038\/icb.2012.9","DOI":"10.1038\/icb.2012.9"},{"key":"12180_CR20","doi-asserted-by":"publisher","unstructured":"Binnewies M, Roberts EW, Kersten K, Chan V, Fearon DF, Merad M et al (2018) Understanding the tumor immune microenvironment (TIME) for effective therapy. Nature Medicine [Internet]. 24(5):541\u201350. Available from: https:\/\/doi.org\/10.1038\/s41591-018-0014-x","DOI":"10.1038\/s41591-018-0014-x"},{"key":"12180_CR21","doi-asserted-by":"publisher","unstructured":"Lee DW, Gardner R, Porter DL, Louis CU, Ahmed N, Jensen M et al (2014) Current concepts in the diagnosis and management of cytokine release syndrome. Blood [Internet]. 124(2):188\u201395. Available from: https:\/\/doi.org\/10.1182\/blood-2014-05-552729","DOI":"10.1182\/blood-2014-05-552729"},{"key":"12180_CR22","doi-asserted-by":"publisher","unstructured":"Chou W, Canchola A, Zhang F, Lin Z (Jul. 2025) Machine learning and artificial intelligence in nanomedicine. Wiley Interdisciplinary Reviews Nanomed Nanobiotechnol 17(4):e70027. https:\/\/doi.org\/10.1002\/wnan.70027","DOI":"10.1002\/wnan.70027"},{"key":"12180_CR23","doi-asserted-by":"publisher","unstructured":"Szebeni J (2005) Complement activation-related pseudoallergy: A new class of drug-induced acute immune toxicity. Toxicology [Internet]. 216(2\u20133):106\u201321. Available from: https:\/\/doi.org\/10.1016\/j.tox.2005.07.023","DOI":"10.1016\/j.tox.2005.07.023"},{"key":"12180_CR24","doi-asserted-by":"publisher","unstructured":"Park W, Heo YJ, Han DK (2018) New opportunities for nanoparticles in cancer immunotherapy. Biomaterials Research [Internet]. 22(1):24. Available from: https:\/\/doi.org\/10.1186\/s40824-018-0133-y","DOI":"10.1186\/s40824-018-0133-y"},{"key":"12180_CR25","doi-asserted-by":"publisher","unstructured":"Shi Y, Van Der Meel R, Chen X, Lammers T (2020) The EPR effect and beyond: Strategies to improve tumor targeting and cancer nanomedicine treatment efficacy. Theranostics [Internet]. 10(17):7921\u20134. Available from: https:\/\/doi.org\/10.7150\/thno.49577","DOI":"10.7150\/thno.49577"},{"key":"12180_CR26","doi-asserted-by":"publisher","unstructured":"Hadjidemetriou M, Kostarelos K (2017) Evolution of the nanoparticle corona. Nature Nanotechnology [Internet]. 12(4):288\u201390. Available from: https:\/\/doi.org\/10.1038\/nnano.2017.61","DOI":"10.1038\/nnano.2017.61"},{"key":"12180_CR27","doi-asserted-by":"publisher","unstructured":"Szebeni J, Storm G (2015) Complement activation as a bioequivalence issue relevant to the development of generic liposomes and other nanoparticulate drugs. Biochemical and Biophysical Research Communications [Internet]. 468(3):490\u20137. Available from: https:\/\/doi.org\/10.1016\/j.bbrc.2015.06.177","DOI":"10.1016\/j.bbrc.2015.06.177"},{"key":"12180_CR28","doi-asserted-by":"publisher","unstructured":"Schoenmaker L, Witzigmann D, Kulkarni JA, Verbeke R, Kersten G, Jiskoot W et al (2021) mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability. International Journal of Pharmaceutics [Internet]. 601:120586. Available from: https:\/\/doi.org\/10.1016\/j.ijpharm.2021.120586","DOI":"10.1016\/j.ijpharm.2021.120586"},{"key":"12180_CR29","doi-asserted-by":"publisher","unstructured":"Lv H, Zhang S, Wang B, Cui S, Yan J (2006) Toxicity of cationic lipids and cationic polymers in gene delivery. Journal of Controlled Release [Internet]. 114(1):100\u20139. Available from: https:\/\/doi.org\/10.1016\/j.jconrel.2006.04.014","DOI":"10.1016\/j.jconrel.2006.04.014"},{"key":"12180_CR30","doi-asserted-by":"publisher","unstructured":"Siegwart DJ, Whitehead KA, Nuhn L, Sahay G, Cheng H, Jiang S et al (2011) Combinatorial synthesis of chemically diverse core-shell nanoparticles for intracellular delivery. Proceedings of the National Academy of Sciences [Internet]. 108(32):12996\u20133001. Available from: https:\/\/doi.org\/10.1073\/pnas.1106379108","DOI":"10.1073\/pnas.1106379108"},{"key":"12180_CR31","doi-asserted-by":"publisher","unstructured":"Jiang S, Cao Z (2009) Ultralow-Fouling, functionalizable, and hydrolyzable zwitterionic materials and their derivatives for biological applications. Advanced Materials [Internet]. 22(9):920\u201332. Available from: https:\/\/doi.org\/10.1002\/adma.200901407","DOI":"10.1002\/adma.200901407"},{"key":"12180_CR32","doi-asserted-by":"publisher","unstructured":"Meng H, Liong M, Xia T, Li Z, Ji Z, Zink JI et al (2010) Engineered design of mesoporous silica nanoparticles to deliver doxorubicin and P-Glycoprotein SIRNA to overcome drug resistance in a cancer cell line. ACS Nano [Internet]. 4(8):4539\u201350. Available from: https:\/\/doi.org\/10.1021\/nn100690m","DOI":"10.1021\/nn100690m"},{"key":"12180_CR33","doi-asserted-by":"publisher","unstructured":"Kalluri R, LeBleu VS (2020) The biology, function and biomedical applications of exosomes. Science [Internet]. 367(6478). Available from: https:\/\/doi.org\/10.1126\/science.aau6977","DOI":"10.1126\/science.aau6977"},{"key":"12180_CR34","doi-asserted-by":"publisher","unstructured":"Vader P, Mol EA, Pasterkamp G, Schiffelers RM (2016) Extracellular vesicles for drug delivery. Advanced Drug Delivery Reviews [Internet]. 106(Pt A):148\u201356. Available from: https:\/\/doi.org\/10.1016\/j.addr.2016.02.006","DOI":"10.1016\/j.addr.2016.02.006"},{"key":"12180_CR35","doi-asserted-by":"publisher","unstructured":"Lee YS, Kim SW (2014) Bioreducible polymers for therapeutic gene delivery. Journal of Controlled Release [Internet]. 190:424\u201339. Available from: https:\/\/doi.org\/10.1016\/j.jconrel.2014.04.012","DOI":"10.1016\/j.jconrel.2014.04.012"},{"key":"12180_CR36","doi-asserted-by":"publisher","unstructured":"Fang RH, Kroll AV, Gao W, Zhang L (2018) Cell membrane coating Nanotechnology. Advanced Materials [Internet]. 30(23):e1706759. Available from: https:\/\/doi.org\/10.1002\/adma.201706759","DOI":"10.1002\/adma.201706759"},{"key":"12180_CR37","doi-asserted-by":"publisher","unstructured":"Tenzer S, Docter D, Kuharev J, Musyanovych A, Fetz V, Hecht R et al (2013) Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology. Nature Nanotechnology [Internet]. 8(10):772\u201381. Available from: https:\/\/doi.org\/10.1038\/nnano.2013.181","DOI":"10.1038\/nnano.2013.181"},{"key":"12180_CR38","doi-asserted-by":"publisher","unstructured":"Li Y, Xiao K, Zhu W, Deng W, Lam KS (2013) Stimuli-responsive cross-linked micelles for on-demand drug delivery against cancers. Advanced Drug Delivery Reviews [Internet]. 66:58\u201373. Available from: https:\/\/doi.org\/10.1016\/j.addr.2013.09.008","DOI":"10.1016\/j.addr.2013.09.008"},{"key":"12180_CR39","doi-asserted-by":"publisher","unstructured":"Blanco E, Shen H, Ferrari M (2015) Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nature Biotechnology [Internet]. 33(9):941\u201351. Available from: https:\/\/doi.org\/10.1038\/nbt.3330","DOI":"10.1038\/nbt.3330"},{"key":"12180_CR40","doi-asserted-by":"publisher","unstructured":"Chen Q, Xu L, Liang C, Wang C, Peng R, Liu Z (2016) Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy. Nature Communications [Internet]. 7(1):13193. Available from: https:\/\/doi.org\/10.1038\/ncomms13193","DOI":"10.1038\/ncomms13193"},{"key":"12180_CR41","doi-asserted-by":"publisher","unstructured":"Shiraishi K, Yokoyama M (2019) Toxicity and immunogenicity concerns related to PEGylated-micelle carrier systems: a review. Science and Technology of Advanced Materials [Internet]. 20(1):324\u201336. Available from: https:\/\/doi.org\/10.1080\/14686996.2019.1590126","DOI":"10.1080\/14686996.2019.1590126"},{"key":"12180_CR42","doi-asserted-by":"publisher","unstructured":"Tian Y, Lv H, Ju Y, Hao J, Cui J (2025) Zwitterionic Poly(ethylene glycol) Nanoparticles Minimize Protein Adsorption and Immunogenicity for Improved Biological Fate. ACS Applied Materials & Interfaces [Internet]. 17(4):6125\u201333. Available from: https:\/\/doi.org\/10.1021\/acsami.4c20890","DOI":"10.1021\/acsami.4c20890"},{"key":"12180_CR43","doi-asserted-by":"publisher","unstructured":"Szebeni J (2005) Complement Activation-Related pseudoallergy caused by amphiphilic drug carriers: The role of lipoproteins. Current Drug Delivery [Internet]. 2(4):443\u20139. Available from: https:\/\/doi.org\/10.2174\/156720105774370212","DOI":"10.2174\/156720105774370212"},{"key":"12180_CR44","doi-asserted-by":"publisher","unstructured":"Moghimi SM, Simberg D (2017) Complement activation turnover on surfaces of nanoparticles. Nano Today [Internet]. 15:8\u201310. Available from: https:\/\/doi.org\/10.1016\/j.nantod.2017.03.001","DOI":"10.1016\/j.nantod.2017.03.001"},{"key":"12180_CR45","doi-asserted-by":"publisher","unstructured":"Monopoli MP, \u00c5berg C, Salvati A, Dawson KA (2012) Biomolecular coronas provide the biological identity of nanosized materials. Nature Nanotechnology [Internet]. 7(12):779\u201386. Available from: https:\/\/doi.org\/10.1038\/nnano.2012.207","DOI":"10.1038\/nnano.2012.207"},{"key":"12180_CR46","doi-asserted-by":"publisher","unstructured":"Peng Q, Zhang S, Yang Q, Zhang T, Wei XQ, Jiang L et al (2013) Preformed albumin corona, a protective coating for nanoparticles based drug delivery system. Biomaterials [Internet]. 34(33):8521\u201330. Available from: https:\/\/doi.org\/10.1016\/j.biomaterials.2013.07.102","DOI":"10.1016\/j.biomaterials.2013.07.102"},{"key":"12180_CR47","doi-asserted-by":"publisher","unstructured":"Singh N, Marets C, Boudon J, Millot N, Saviot L, Maurizi L (2021) In vivo protein corona on nanoparticles: does the control of all material parameters orient the biological behavior? Nanoscale Advances [Internet]. 3(5):1209\u201329. Available from: https:\/\/doi.org\/10.1039\/d0na00863j","DOI":"10.1039\/d0na00863j"},{"key":"12180_CR48","doi-asserted-by":"publisher","unstructured":"Bertrand N, Wu J, Xu X, Kamaly N, Farokhzad OC (2013) Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology. Advanced Drug Delivery Reviews [Internet]. 66:2\u201325. Available from: https:\/\/doi.org\/10.1016\/j.addr.2013.11.009","DOI":"10.1016\/j.addr.2013.11.009"},{"key":"12180_CR49","doi-asserted-by":"publisher","unstructured":"Appel EA, Tibbitt MW, Webber MJ, Mattix BA, Veiseh O, Langer R (2015) Self-assembled hydrogels utilizing polymer\u2013nanoparticle interactions. Nature Communications [Internet]. 6(1):6295. Available from: https:\/\/doi.org\/10.1038\/ncomms7295","DOI":"10.1038\/ncomms7295"},{"key":"12180_CR50","doi-asserted-by":"publisher","unstructured":"Wilhelm S, Tavares AJ, Dai Q, Ohta S, Audet J, Dvorak HF et al (2016) Analysis of nanoparticle delivery to tumours. Nature Reviews Materials [Internet]. 1(5). Available from: https:\/\/doi.org\/10.1038\/natrevmats.2016.14","DOI":"10.1038\/natrevmats.2016.14"},{"key":"12180_CR51","doi-asserted-by":"publisher","unstructured":"Zhao Z, Ukidve A, Kim J, Mitragotri S (2020) Targeting strategies for Tissue-Specific drug delivery. Cell [Internet]. 181(1):151\u201367. Available from: https:\/\/doi.org\/10.1016\/j.cell.2020.02.001","DOI":"10.1016\/j.cell.2020.02.001"},{"key":"12180_CR52","doi-asserted-by":"publisher","unstructured":"Nichols JW, Bae YH (2014) EPR: Evidence and fallacy. Journal of Controlled Release [Internet]. 190:451\u201364. Available from: https:\/\/doi.org\/10.1016\/j.jconrel.2014.03.057","DOI":"10.1016\/j.jconrel.2014.03.057"},{"key":"12180_CR53","doi-asserted-by":"publisher","unstructured":"Sindhwani S, Syed AM, Ngai J, Kingston BR, Maiorino L, Rothschild J et al (2020) The entry of nanoparticles into solid tumours. Nature Materials [Internet]. 19(5):566\u201375. Available from: https:\/\/doi.org\/10.1038\/s41563-019-0566-2","DOI":"10.1038\/s41563-019-0566-2"},{"key":"12180_CR54","doi-asserted-by":"publisher","unstructured":"Danhier F (2016) To exploit the tumor microenvironment: Since the EPR effect fails in the clinic, what is the future of nanomedicine? Journal of Controlled Release [Internet]. 244(Pt A):108\u201321. Available from: https:\/\/doi.org\/10.1016\/j.jconrel.2016.11.015","DOI":"10.1016\/j.jconrel.2016.11.015"},{"key":"12180_CR55","doi-asserted-by":"publisher","unstructured":"Ekladious I, Colson YL, Grinstaff MW (2018) Polymer\u2013drug conjugate therapeutics: advances, insights and prospects. Nature Reviews Drug Discovery [Internet]. 18(4):273\u201394. Available from: https:\/\/doi.org\/10.1038\/s41573-018-0005-0","DOI":"10.1038\/s41573-018-0005-0"},{"key":"12180_CR56","doi-asserted-by":"publisher","unstructured":"Zhou J, Rossi J (2016) Aptamers as targeted therapeutics: current potential and challenges. Nature Reviews Drug Discovery [Internet]. 16(3):181\u2013202. Available from: https:\/\/doi.org\/10.1038\/nrd.2016.199","DOI":"10.1038\/nrd.2016.199"},{"key":"12180_CR57","doi-asserted-by":"publisher","unstructured":"Torchilin VP (2014) Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery. Nature Reviews Drug Discovery [Internet]. 13(11):813\u201327. Available from: https:\/\/doi.org\/10.1038\/nrd4333","DOI":"10.1038\/nrd4333"},{"key":"12180_CR58","doi-asserted-by":"publisher","unstructured":"Poon Z, Chang D, Zhao X, Hammond PT (2011) Layer-by-layer nanoparticles with a pH-sheddable layer forin vivotargeting of tumor hypoxia. ACS Nano [Internet]. 5(6):4284\u201392. Available from: https:\/\/doi.org\/10.1021\/nn200876f","DOI":"10.1021\/nn200876f"},{"key":"12180_CR59","doi-asserted-by":"publisher","unstructured":"Yin H, Kanasty RL, Eltoukhy AA, Vegas AJ, Dorkin JR, Anderson DG (2014) Non-viral vectors for gene-based therapy. Nature Reviews Genetics [Internet]. 15(8):541\u201355. Available from: https:\/\/doi.org\/10.1038\/nrg3763","DOI":"10.1038\/nrg3763"},{"key":"12180_CR60","doi-asserted-by":"publisher","unstructured":"Kowalski PS, Rudra A, Miao L, Anderson DG (2019) Delivering the Messenger: Advances in technologies for therapeutic mRNA delivery. Molecular Therapy [Internet]. 27(4):710\u201328. Available from: https:\/\/doi.org\/10.1016\/j.ymthe.2019.02.012","DOI":"10.1016\/j.ymthe.2019.02.012"},{"key":"12180_CR61","doi-asserted-by":"publisher","unstructured":"Lino CA, Harper JC, Carney JP, Timlin JA (2018) Delivering CRISPR: a review of the challenges and approaches. Drug Delivery [Internet]. 25(1):1234\u201357. Available from: https:\/\/doi.org\/10.1080\/10717544.2018.1474964","DOI":"10.1080\/10717544.2018.1474964"},{"key":"12180_CR62","doi-asserted-by":"publisher","unstructured":"Kulkarni JA, Darjuan MM, Mercer JE, Chen S, Van Der Meel R, Thewalt JL et al (2018) On the formation and morphology of lipid nanoparticles containing ionizable cationic lipids and siRNA. ACS Nano [Internet]. 12(5):4787\u201395. Available from: https:\/\/doi.org\/10.1021\/acsnano.8b01516","DOI":"10.1021\/acsnano.8b01516"},{"key":"12180_CR63","doi-asserted-by":"publisher","unstructured":"Ramishetti S, Kedmi R, Goldsmith M, Leonard F, Sprague AG, Godin B et al (2015) Systemic gene silencing in primary T lymphocytes using targeted lipid nanoparticles. ACS Nano [Internet]. 9(7):6706\u201316. Available from: https:\/\/doi.org\/10.1021\/acsnano.5b02796","DOI":"10.1021\/acsnano.5b02796"},{"key":"12180_CR64","doi-asserted-by":"publisher","unstructured":"Sahin U, Karik\u00f3 K, T\u00fcreci \u00d6 (2014) mRNA-based therapeutics \u2014 developing a new class of drugs. Nature Reviews Drug Discovery [Internet]. 13(10):759\u201380. Available from: https:\/\/doi.org\/10.1038\/nrd4278","DOI":"10.1038\/nrd4278"},{"key":"12180_CR65","doi-asserted-by":"publisher","unstructured":"Cristofoletti R, Hens B, Patel N, Esteban VV, Schmidt S, Dressman J (2019) Integrating Drug- and Formulation-Related properties with gastrointestinal tract variability using a Product-Specific particle size approach: case example ibuprofen. Journal of Pharmaceutical Sciences [Internet]. 108(12):3842\u20137. Available from: https:\/\/doi.org\/10.1016\/j.xphs.2019.09.012","DOI":"10.1016\/j.xphs.2019.09.012"},{"key":"12180_CR66","doi-asserted-by":"publisher","unstructured":"Hassett KJ, Benenato KE, Jacquinet E, Lee A, Woods A, Yuzhakov O et al (2019) Optimization of lipid nanoparticles for intramuscular administration of mRNA vaccines. Molecular Therapy \u2014 Nucleic Acids [Internet]. 15:1\u201311. Available from: https:\/\/doi.org\/10.1016\/j.omtn.2019.01.013","DOI":"10.1016\/j.omtn.2019.01.013"},{"key":"12180_CR67","doi-asserted-by":"publisher","unstructured":"Pardi N, Hogan MJ, Weissman D (2020) Recent advances in mRNA vaccine technology. Current Opinion in Immunology [Internet]. 65:14\u201320. Available from: https:\/\/doi.org\/10.1016\/j.coi.2020.01.008","DOI":"10.1016\/j.coi.2020.01.008"},{"key":"12180_CR68","doi-asserted-by":"publisher","unstructured":"Juliano RL (2016) The delivery of therapeutic oligonucleotides. Nucleic Acids Research [Internet]. 44(14):6518\u201348. Available from: https:\/\/doi.org\/10.1093\/nar\/gkw236","DOI":"10.1093\/nar\/gkw236"},{"key":"12180_CR69","doi-asserted-by":"publisher","unstructured":"Yang Q, Lai SK (2015) Anti-PEG immunity: emergence, characteristics, and unaddressed questions. Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology [Internet]. 7(5):655\u201377. Available from: https:\/\/doi.org\/10.1002\/wnan.1339","DOI":"10.1002\/wnan.1339"},{"key":"12180_CR70","doi-asserted-by":"publisher","unstructured":"Charlesworth CT, Deshpande PS, Dever DP, Camarena J, Lemgart VT, Cromer MK et al (2019) Identification of preexisting adaptive immunity to Cas9 proteins in humans. Nature Medicine [Internet]. 25(2):249\u201354. Available from: https:\/\/doi.org\/10.1038\/s41591-018-0326-x","DOI":"10.1038\/s41591-018-0326-x"},{"key":"12180_CR71","doi-asserted-by":"publisher","unstructured":"Anselmo AC, Mitragotri S. Nanoparticles in the clinic: An update., Bioengineering (2019) & Translational Medicine [Internet]. 4(3):e10143. Available from: https:\/\/doi.org\/10.1002\/btm2.10143","DOI":"10.1002\/btm2.10143"},{"key":"12180_CR72","doi-asserted-by":"publisher","unstructured":"Young TL, Wang KC, Varley AJ, Li B (2023) Clinical delivery of circular RNA: Lessons learned from RNA drug development. Advanced Drug Delivery Reviews [Internet]. 197:114826. Available from: https:\/\/doi.org\/10.1016\/j.addr.2023.114826","DOI":"10.1016\/j.addr.2023.114826"},{"key":"12180_CR73","doi-asserted-by":"publisher","unstructured":"Wang D, Zhang F, Gao G (2020) CRISPR-Based Therapeutic Genome Editing: strategies and in vivo delivery by AAV vectors. Cell [Internet]. 181(1):136\u201350. Available from: https:\/\/doi.org\/10.1016\/j.cell.2020.03.023","DOI":"10.1016\/j.cell.2020.03.023"},{"key":"12180_CR74","doi-asserted-by":"publisher","unstructured":"Nam J, Son S, Park KS, Zou W, Shea LD, Moon JJ (2019) Cancer nanomedicine for combination cancer immunotherapy. Nature Reviews Materials [Internet]. 4(6):398\u2013414. Available from: https:\/\/doi.org\/10.1038\/s41578-019-0108-1","DOI":"10.1038\/s41578-019-0108-1"},{"key":"12180_CR75","doi-asserted-by":"publisher","unstructured":"Nel AE, M\u00e4dler L, Velegol D, Xia T, Hoek EMV, Somasundaran P et al (2009) Understanding biophysicochemical interactions at the nano\u2013bio interface. Nature Materials [Internet]. 8(7):543\u201357. Available from: https:\/\/doi.org\/10.1038\/nmat2442","DOI":"10.1038\/nmat2442"},{"key":"12180_CR76","doi-asserted-by":"publisher","unstructured":"Albanese A, Tang PS, Chan WCW (2012) The effect of nanoparticle size, shape, and surface chemistry on biological systems. Annual Review of Biomedical Engineering [Internet]. 14(1):1\u201316. Available from: https:\/\/doi.org\/10.1146\/annurev-bioeng-071811-150124","DOI":"10.1146\/annurev-bioeng-071811-150124"},{"key":"12180_CR77","doi-asserted-by":"publisher","unstructured":"Lila ASA, Kiwada H, Ishida T (2013) The accelerated blood clearance (ABC) phenomenon: Clinical challenge and approaches to manage. Journal of Controlled Release [Internet]. 172(1):38\u201347. Available from: https:\/\/doi.org\/10.1016\/j.jconrel.2013.07.026","DOI":"10.1016\/j.jconrel.2013.07.026"},{"key":"12180_CR78","doi-asserted-by":"publisher","unstructured":"Alexis F, Rhee JW, Richie JP, Radovic-Moreno AF, Langer R, Farokhzad OC (2008) New frontiers in nanotechnology for cancer treatment. Urologic Oncology Seminars and Original Investigations [Internet]. 26(1):74\u201385. Available from: https:\/\/doi.org\/10.1016\/j.urolonc.2007.03.017","DOI":"10.1016\/j.urolonc.2007.03.017"},{"key":"12180_CR79","doi-asserted-by":"publisher","unstructured":"Etheridge ML, Campbell SA, Erdman AG, Haynes CL, Wolf SM, McCullough J (2012) The big picture on nanomedicine: the state of investigational and approved nanomedicine products. Nanomedicine Nanotechnology Biology and Medicine [Internet]. 9(1):1\u201314. Available from: https:\/\/doi.org\/10.1016\/j.nano.2012.05.013","DOI":"10.1016\/j.nano.2012.05.013"},{"key":"12180_CR80","doi-asserted-by":"publisher","unstructured":"Ashley CE, Carnes EC, Phillips GK, Padilla D, Durfee PN, Brown PA et al (2011) The targeted delivery of multicomponent cargos to cancer cells by nanoporous particle-supported lipid bilayers. Nature Materials [Internet]. 10(5):389\u201397. Available from: https:\/\/doi.org\/10.1038\/nmat2992","DOI":"10.1038\/nmat2992"},{"key":"12180_CR81","doi-asserted-by":"publisher","unstructured":"Marabelle A, Tselikas L, De Baere T, Houot R (2017) Intratumoral immunotherapy: using the tumor as the remedy. Annals of Oncology [Internet]. 28(suppl_12):xii33\u201343. Available from: https:\/\/doi.org\/10.1093\/annonc\/mdx683","DOI":"10.1093\/annonc\/mdx683"},{"key":"12180_CR82","doi-asserted-by":"publisher","unstructured":"Li J, Kataoka K (2020) Chemo-physical strategies to advance the in vivo functionality of targeted nanomedicine: the next generation. Journal of the American Chemical Society [Internet]. 143(2):538\u201359. Available from: https:\/\/doi.org\/10.1021\/jacs.0c09029","DOI":"10.1021\/jacs.0c09029"},{"key":"12180_CR83","doi-asserted-by":"publisher","unstructured":"Roberts TC, Langer R, Wood MJA (2020) Advances in oligonucleotide drug delivery. Nature Reviews Drug Discovery [Internet]. 19(10):673\u201394. Available from: https:\/\/doi.org\/10.1038\/s41573-020-0075-7","DOI":"10.1038\/s41573-020-0075-7"},{"key":"12180_CR84","doi-asserted-by":"publisher","unstructured":"Dobrovolskaia MA, McNeil SE (2013) Understanding the correlation between in vitro and in vivo immunotoxicity tests for nanomedicines. Journal of Controlled Release [Internet]. 172(2):456\u201366. Available from: https:\/\/doi.org\/10.1016\/j.jconrel.2013.05.025","DOI":"10.1016\/j.jconrel.2013.05.025"},{"key":"12180_CR85","doi-asserted-by":"publisher","unstructured":"Maudens P, Seemayer CA, Pfefferl\u00e9 F, Jordan O, All\u00e9mann E (2018) Nanocrystals of a potent p38 MAPK inhibitor embedded in microparticles: Therapeutic effects in inflammatory and mechanistic murine models of osteoarthritis. Journal of Controlled Release [Internet]. 276:102\u201312. Available from: https:\/\/doi.org\/10.1016\/j.jconrel.2018.03.007","DOI":"10.1016\/j.jconrel.2018.03.007"},{"key":"12180_CR86","doi-asserted-by":"publisher","unstructured":"Anselmo AC, Mitragotri S (2015) A review of Clinical translation of inorganic nanoparticles. The AAPS Journal [Internet]. 17(5):1041\u201354. Available from: https:\/\/doi.org\/10.1208\/s12248-015-9780-2","DOI":"10.1208\/s12248-015-9780-2"},{"key":"12180_CR87","doi-asserted-by":"publisher","unstructured":"Takata H, Shimizu T, Yamade R, Elsadek NE, Emam SE, Ando H et al (2023) Anti-PEG IgM production induced by PEGylated liposomes as a function of administration route. Journal of Controlled Release [Internet]. 360:285\u201392. Available from: https:\/\/doi.org\/10.1016\/j.jconrel.2023.06.027","DOI":"10.1016\/j.jconrel.2023.06.027"},{"key":"12180_CR88","doi-asserted-by":"publisher","unstructured":"Cedervall T et al (2007) Understanding the nanoparticle\u2013protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles, Proceedings of the National Academy of Sciences, vol. 104, no. 7, pp. 2050\u20132055, Feb. https:\/\/doi.org\/10.1073\/pnas.0608582104","DOI":"10.1073\/pnas.0608582104"},{"key":"12180_CR89","doi-asserted-by":"publisher","unstructured":"Elsabahy M, Wooley KL (2013) Cytokines as biomarkers of nanoparticle immunotoxicity. Chemical Society Reviews [Internet]. 42(12):5552. Available from: https:\/\/doi.org\/10.1039\/c3cs60064e","DOI":"10.1039\/c3cs60064e"},{"key":"12180_CR90","doi-asserted-by":"publisher","unstructured":"Coffman RL, Sher A, Seder RA (2010) Vaccine adjuvants: Putting innate immunity to work. Immunity [Internet]. 33(4):492\u2013503. Available from: https:\/\/doi.org\/10.1016\/j.immuni.2010.10.002","DOI":"10.1016\/j.immuni.2010.10.002"},{"key":"12180_CR91","doi-asserted-by":"publisher","unstructured":"Mosely SIS, Prime JE, Sainson RCA, Koopmann JO, Wang DYQ, Greenawalt DM et al (2016) Rational selection of syngeneic preclinical tumor models for immunotherapeutic drug discovery. Cancer Immunology Research [Internet]. 5(1):29\u201341. Available from: https:\/\/doi.org\/10.1158\/2326-6066.cir-16-0114","DOI":"10.1158\/2326-6066.cir-16-0114"},{"key":"12180_CR92","doi-asserted-by":"publisher","unstructured":"Hare JI, Lammers T, Ashford MB, Puri S, Storm G, Barry ST (2016) Challenges and strategies in anti-cancer nanomedicine development: An industry perspective. Advanced Drug Delivery Reviews [Internet]. 108:25\u201338. Available from: https:\/\/doi.org\/10.1016\/j.addr.2016.04.025","DOI":"10.1016\/j.addr.2016.04.025"},{"key":"12180_CR93","doi-asserted-by":"publisher","unstructured":"Takao K, Miyakawa T (2014) Genomic responses in mouse models greatly mimic human inflammatory diseases. Proceedings of the National Academy of Sciences [Internet]. 112(4):1167\u201372. Available from: https:\/\/doi.org\/10.1073\/pnas.1401965111","DOI":"10.1073\/pnas.1401965111"},{"key":"12180_CR94","doi-asserted-by":"publisher","unstructured":"Alexis F, Pridgen E, Molnar LK, Farokhzad OC (2008) Factors affecting the clearance and biodistribution of polymeric nanoparticles. Molecular Pharmaceutics [Internet]. ;5(4):505\u201315. Available from: https:\/\/doi.org\/10.1021\/mp800051m","DOI":"10.1021\/mp800051m"},{"key":"12180_CR95","doi-asserted-by":"publisher","unstructured":"Tsoi KM, MacParland SA, Ma XZ, Spetzler VN, Echeverri J, Ouyang B et al (2016) Mechanism of hard-nanomaterial clearance by the liver. Nature Materials [Internet]. 15(11):1212\u201321. Available from: https:\/\/doi.org\/10.1038\/nmat4718","DOI":"10.1038\/nmat4718"},{"key":"12180_CR96","doi-asserted-by":"publisher","unstructured":"Cagney DN, Sul J, Huang RY, Ligon KL, Wen PY, Alexander BM (2017) The FDA NIH Biomarkers, EndpointS, and other Tools (BEST) resource in neuro-oncology. Neuro-Oncology [Internet]. 20(9):1162\u201372. Available from: https:\/\/doi.org\/10.1093\/neuonc\/nox242","DOI":"10.1093\/neuonc\/nox242"},{"key":"12180_CR97","doi-asserted-by":"publisher","unstructured":"Faria M, Bj\u00f6rnmalm M, Thurecht KJ, Kent SJ, Parton RG, Kavallaris M et al (2018) Minimum information reporting in bio\u2013nano experimental literature. Nature Nanotechnology [Internet]. 13(9):777\u201385. Available from: https:\/\/doi.org\/10.1038\/s41565-018-0246-4","DOI":"10.1038\/s41565-018-0246-4"},{"key":"12180_CR98","doi-asserted-by":"publisher","unstructured":"Li X, Qi J, Wang J, Hu W, Zhou W, Wang Y et al (2024) Nanoparticle technology for mRNA: Delivery strategy, clinical application and developmental landscape. Theranostics [Internet]. 14(2):738\u201360. Available from: https:\/\/doi.org\/10.7150\/thno.84291","DOI":"10.7150\/thno.84291"},{"issue":"4","key":"12180_CR99","first-page":"577","volume":"16","author":"M Anupama Ammulu","year":"2022","unstructured":"Anupama Ammulu M, Durga Devi NK, Praveen Kumar V, Chowdary MS, Poda S (2022) COVID-19: a new insight into organ failure and complications caused by novel SARS-CoV-2 virus and discussion on the role of nanotechnology in detection, treatment and prevention. Curr Trends Biotechnol Pharm 16(4):577\u2013602","journal-title":"Curr Trends Biotechnol Pharm"},{"key":"12180_CR100","doi-asserted-by":"publisher","unstructured":"Fadeel B (2019) Hide and Seek: Nanomaterial interactions with the immune system. Frontiers in Immunology [Internet]. ;10:133. Available from: https:\/\/doi.org\/10.3389\/fimmu.2019.00133","DOI":"10.3389\/fimmu.2019.00133"},{"key":"12180_CR101","doi-asserted-by":"publisher","unstructured":"Teeguarden JG, Housand CJ, Smith JN, Hinderliter PM, Gunawan R, Timchalk CA (2012) A multi-route model of nicotine\u2013cotinine pharmacokinetics, pharmacodynamics and brain nicotinic acetylcholine receptor binding in humans. Regulatory Toxicology and Pharmacology [Internet]. 65(1):12\u201328. Available from: https:\/\/doi.org\/10.1016\/j.yrtph.2012.10.007","DOI":"10.1016\/j.yrtph.2012.10.007"},{"key":"12180_CR102","doi-asserted-by":"publisher","unstructured":"Shi J, Kantoff PW, Wooster R, Farokhzad OC (2016) Cancer nanomedicine: progress, challenges and opportunities, Nature Reviews. Cancer, vol. 17, no. 1, pp. 20\u201337, Nov. https:\/\/doi.org\/10.1038\/nrc.2016.108","DOI":"10.1038\/nrc.2016.108"},{"key":"12180_CR103","doi-asserted-by":"publisher","unstructured":"Postel-Vinay S, Collette L, Paoletti X, Rizzo E, Massard C, Olmos D et al (2014) Towards new methods for the determination of dose limiting toxicities and the assessment of the recommended dose for further studies of molecularly targeted agents \u2013 Dose-Limiting Toxicity and Toxicity Assessment Recommendation Group for Early Trials of Targeted therapies, an European Organisation for Research and Treatment of Cancer-led study. European Journal of Cancer [Internet]. 50(12):2040\u20139. Available from: https:\/\/doi.org\/10.1016\/j.ejca.2014.04.031","DOI":"10.1016\/j.ejca.2014.04.031"},{"key":"12180_CR104","doi-asserted-by":"publisher","unstructured":"Shepherd SJ, Issadore D, Mitchell MJ (2021) Microfluidic formulation of nanoparticles for biomedical applications. Biomaterials [Internet]. 274:120826. Available from: https:\/\/doi.org\/10.1016\/j.biomaterials.2021.120826","DOI":"10.1016\/j.biomaterials.2021.120826"},{"key":"12180_CR105","doi-asserted-by":"publisher","unstructured":"Bobo D, Robinson KJ, Islam J, Thurecht KJ, Corrie SR (2016) Nanoparticle-Based Medicines: A review of FDA-Approved materials and clinical trials to date. Pharmaceutical Research [Internet]. 33(10):2373\u201387. Available from: https:\/\/doi.org\/10.1007\/s11095-016-1958-5","DOI":"10.1007\/s11095-016-1958-5"},{"key":"12180_CR106","doi-asserted-by":"publisher","unstructured":"Tinkle S, McNeil SE, M\u00fchlebach S, Bawa R, Borchard G, Barenholz Y et al (2014) Nanomedicines: addressing the scientific and regulatory gap. Annals of the New York Academy of Sciences [Internet]. 1313(1):35\u201356. Available from: https:\/\/doi.org\/10.1111\/nyas.12403","DOI":"10.1111\/nyas.12403"},{"key":"12180_CR107","doi-asserted-by":"publisher","unstructured":"Dobrovolskaia MA (2015) Pre-clinical immunotoxicity studies of nanotechnology-formulated drugs: Challenges, considerations and strategy. Journal of Controlled Release [Internet]. 220(Pt B):571\u201383. Available from: https:\/\/doi.org\/10.1016\/j.jconrel.2015.08.056","DOI":"10.1016\/j.jconrel.2015.08.056"},{"key":"12180_CR108","doi-asserted-by":"publisher","unstructured":"M\u00fchlebach S, Borchard G, Yildiz S (2015) Regulatory Challenges and Approaches to Characterize Nanomedicines and their Follow-On Similars. Nanomedicine [Internet]. ;10(4):659\u201374. Available from: https:\/\/doi.org\/10.2217\/nnm.14.189","DOI":"10.2217\/nnm.14.189"},{"key":"12180_CR109","doi-asserted-by":"publisher","unstructured":"Diken M, Kranz LM, Kreiter S, Sahin U (2016) MRNA: a versatile molecule for cancer vaccines. Current Issues in Molecular Biology [Internet]. 22:113\u201328. Available from: https:\/\/doi.org\/10.21775\/cimb.022.113","DOI":"10.21775\/cimb.022.113"},{"key":"12180_CR110","doi-asserted-by":"publisher","unstructured":"Jim\u00e9nez-Luna J, Grisoni F, Weskamp N, Schneider G (2021) Artificial intelligence in drug discovery: recent advances and future perspectives. Expert Opinion on Drug Discovery [Internet]. 16(9):949\u201359. Available from: https:\/\/doi.org\/10.1080\/17460441.2021.1909567","DOI":"10.1080\/17460441.2021.1909567"},{"key":"12180_CR111","doi-asserted-by":"publisher","unstructured":"Rodon J, Soria JC, Berger R, Miller WH, Rubin E, Kugel A et al (2019) Genomic and transcriptomic profiling expands precision cancer medicine: the WINTHER trial. Nature Medicine [Internet]. 25(5):751\u20138. Available from: https:\/\/doi.org\/10.1038\/s41591-019-0424-4","DOI":"10.1038\/s41591-019-0424-4"},{"key":"12180_CR112","doi-asserted-by":"publisher","unstructured":"Ribas A, Wolchok JD (2018) Cancer immunotherapy using checkpoint blockade. Science [Internet]. 359(6382):1350\u20135. Available from: https:\/\/doi.org\/10.1126\/science.aar4060","DOI":"10.1126\/science.aar4060"},{"issue":"3","key":"12180_CR113","first-page":"79","volume":"12","author":"D Samyuktha","year":"2022","unstructured":"Samyuktha D, Kumar KA, Anupama MA, BalaVinodK, Kamepalli S, Revanth G, Bhagavan J, Manikanta AS, Durga Devi NK (2022) The essence of all cancer immunotherapy is therapeutic vaccination. Int J InnovEng Manag Res 12(3):79\u201390","journal-title":"Int J InnovEng Manag Res"},{"key":"12180_CR114","doi-asserted-by":"publisher","unstructured":"Metselaar JM, Lammers T (2020) Challenges in nanomedicine clinical translation. Drug Delivery and Translational Research [Internet]. 10(3):721\u20135. Available from: https:\/\/doi.org\/10.1007\/s13346-020-00740-5","DOI":"10.1007\/s13346-020-00740-5"},{"key":"12180_CR115","doi-asserted-by":"publisher","unstructured":"Nelluri KDD, Lakshmi KNVC, Kommoju M, Alaparthi B, Kakani AK, Rohith PS et al (2026) Targeting the extracellular matrix in precision medicine: opportunities for diagnostics and therapeutics. Molecular Biology Reports [Internet]. 53(1). Available from: https:\/\/doi.org\/10.1007\/s11033-026-11624-1","DOI":"10.1007\/s11033-026-11624-1"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12180-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12180-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12180-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T12:34:29Z","timestamp":1782218069000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12180-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,23]]},"references-count":115,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12180"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12180-4","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,23]]},"assertion":[{"value":"4 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial"}}],"article-number":"989"}}